In this study, we established a prognostic signature especially in COAD with TP53 mutations by bioinformatics analysis and evaluated it in both TP53-mutant COAD cohorts and TP53 wild-type cohorts. The gene discussed is TP53; the disease is colon adenocarcinoma.